Aquestive Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Aquestive Therapeutics announces its 2026 Annual Meeting of Stockholders to be held virtually on June 10, 2026.
NASDAQ
Aquestive Therapeutics, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Aquestive Therapeutics will hold its 2025 Annual Meeting of Stockholders virtually on June 11, 2025, to vote on director elections, executive compensation, and the ratification of the company's accounting firm.
NASDAQ
Aquestive Therapeutics, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Aquestive Therapeutics announces its 2024 Annual Meeting of Stockholders to be held virtually on June 20, 2024, to vote on director elections, executive compensation, and auditor ratification.